tirzepatide glp 1 and gip Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control body weight reduction Major physiological roles of GLP-1

Not necessarily, but there's a higher risk of nausea, bloating, or abdominal discomfort if you eat high-fat meals while on tirzepatide

According to trial data, people on Semaglutide had a slightly higher dropout rate due to side effects, but both meds had solid safety profiles overall

The enhanced GI effects may cause temporary water weight shifts, while the stronger appetite suppression can lead to reduced food intake that shows up as an artificially steep drop on the scale

Choosing balanced, whole foods and following proper guidance allows tirzepatide to work more effectively, helping you achieve safe, lasting weight loss